Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February;56(1)

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February;56(1)

FOREWORD  THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):1-3

The impact of molecular imaging in the management of movement disorders: an ongoing revolution

Nobili F., Tatsch K.

PDF

REVIEWS  THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):4-16

The molecular basis of dopaminergic brain imaging in Parkinson’s disease

Seibyl J., Russell D., Jennings D., Marek K.

Abstract PDF

REVIEWS  THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):17-26

The role of molecular imaging in the differential diagnosis of parkinsonism

Booij J., Teune L. K., Verberne H. J.

Abstract PDF

REVIEWS  THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):27-38

Quantitative approaches to dopaminergic brain imaging

Tatsch K., Poepperl G.

Abstract PDF

REVIEWS  THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):39-54

Identification of biomarkers in Lewy-body disorders

Warr L., Walker Z.

Abstract PDF

REVIEWS  THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):55-67

Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging

Arnaldi D., Morbelli S., Morrone E., Campus C., Nobili F.

Abstract PDF

REVIEWS  THE IMPACT OF MOLECULAR IMAGING ON THE MANAGEMENT OF MOVEMENT DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):68-82

New developments of dopaminergic imaging in Parkinson’s disease

Varrone A., Halldin C.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):83-9

Financial aspects of sentinel lymph node biopsy in early breast cancer

Severi S., Gazzoni E., Pellegrini A., Sansovini M., Raulli G., Corbelli C., Altini M., Paganelli G.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 February:56(1):90-8

Clinical indications to the use of 99mTc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors

Parisella M. G., Chianelli M., D’Alessandria C., Todino V., Mikolajczak R., Papini E., Dierckx R. A., Scopinaro F., Signore A.

Abstract PDF

inizio pagina